Back to CVE records
Critical 10.0Known exploited (CISA KEV)Published Dec 18, 2019

CVE-2019-4716IBM Planning Analytics 2.0.0 through 2.0.8 is vulnerable to a configuration overwrite that allows an unauthenticated user to login as "admin", and then execute code as root or SYSTEM via TM1 scriptin…

Updated under an hour ago ()

Does this affect you?

It affects IBM Planning Analytics. Add what you run to find out whether that includes you.

CISA lists it as known exploited since Nov 3, 2021; federal agencies had to remediate by May 3, 2022. Treat that date as your deadline.

IBM Planning Analytics 2.0.0 through 2.0.8 is vulnerable to a configuration overwrite that allows an unauthenticated user to login as "admin", and then execute code as root or SYSTEM via TM1 scripting. IBM X-Force ID: 172094.

CVSS
10.0 CRITICAL (v3.0, CNA)CVSS:3.0/UI:N/AC:L/PR:N/I:H/S:C/AV:N/C:H/A:H/RC:C/RL:O/E:U
Weakness (CWE)
CWE-94
Known exploited
Added to CISA KEV Nov 3, 2021; federal remediation due May 3, 2022Apply updates per vendor instructions.
EPSS (exploitation in the next 30 days)
86.44% (percentile 100)
Assigned by
ibm
NVD analysis
Analyzed
Record last updated
Jan 12, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
IBM Planning Analytics
ibm:planning_analytics (from the name)
2.0.0; 2.0.8
CNA record
ibm planning_analytics
ibm:planning_analytics
from 2.0 through 2.0.8
NVD

References

  • x-refsource-confirm, patch, vendor-advisory
  • vdb-entry, x-refsource-xf, vendor-advisory
  • mailing-list, x-refsource-fulldisc, exploit, third-party-advisory
  • x-refsource-misc, exploit, third-party-advisory, vdb-entry
  • us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.